Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder.
Journal: Drug and alcohol dependence
Published: May 04, 2023
Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.
Journal: The Journal of pharmacology and experimental therapeutics
Published: January 02, 2019
Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: December 18, 2018
Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.
Journal: Journal of clinical pharmacology
Published: December 11, 2018
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.
Journal: Journal of clinical pharmacology
Published: November 05, 2018
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
Journal: Journal of clinical pharmacology
Published: February 26, 2016
Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence.
Journal: Drug and alcohol dependence
Published: December 17, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026